Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A study to test Aumolertinib in European participants with genetically linked advanced Lung Cancer Ended

2024-519618-29-00 Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growt 2025-04-08
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulatio… Ended

2025-520980-41-00 narcolepsy with cataplexy 2025-04-08
A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy … Ended

2024-518134-92-00 ER+/HER2- breast cancer 2025-04-02
A Phase I, Randomised, Investigator- and Participant-blinded, Placebo-Controlled, Study to Assess the Safety, Tolerability, and Pharmacodyna… Ended

2024-519414-31-00 Cardiorenal disease 2025-03-28
A clinical research study investigating how the body processes the new compound petrelintide in people with kidney problems Ended

2024-518124-77-00 Weight management 2025-03-26
Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227 Ended

2024-518734-87-00 No medical condition. 2025-03-25
Oral vs Intravenous Fluids – healthy volunteers Ended

2024-519656-85-00 Hemodynamic parameters is to be investigated -- compari 2025-03-18
Open-label, non-randomised, single-dose, one sequence, two-period, cross-over study to investigate the effect of inhibition of P-glycoprotei… Ended

2024-516475-32-00 Chronic obstructive pulmonary disease 2025-03-17
A study in healthy men to test whether food influences the amount of BI 3731579 in the blood Ended

2024-517895-39-00 Healthy volunteer trial 2025-03-17
A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-… Ended

2024-520126-11-00 Heart Failure 2025-03-14
A randomized, single-blind, placebo-controlled, study to examine the safety, tolerability, and pharmacokinetics of M6229 administered as a 1… Ended

2024-512022-28-01 Sepsis and Septic Shock 2025-03-12
A clinical study of MK-2420 in healthy people (MK-2420-002) Ended

2024-516548-25-00 Rheumatoid arthritis 2025-03-12
Phase I clinical trial to evaluate the pharmacokinetics, safety and tolerability of repeated topical application of PARENTIDE in healthy vol… Ended

2024-516833-11-00 Healthy volunteers 2025-03-12
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTE… Ended

2024-517969-16-00 No therapeutic indication in the current trial with hea 2025-03-12
Not applicable Ended

2024-518150-17-00 Non-cystic fibrosis bronchiectasis 2025-03-10
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4… Ended

2024-516840-24-00 Chronic Kidney disease 2025-03-05
A randomised, open label, single dose, two periods, crossover study of the comparative pharmacokinetics of two alendronic acid formulations … Ended

2024-519666-43-00 not applicable (submitted trial is a pharmacokinetic st 2025-03-04
Neurogenic inflammation upon AITC-induced TRPA1 activation Ended

2025-520494-40-00 Not applicable; this trial investigates a physiological 2025-03-04
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single do… Ended

2024-519661-22-00 Healthy volunteers 2025-03-03
Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D Ended

2023-508054-25-01 Type 2 diabetes 2025-02-26
Measuring the macro- and microvascular responses to LPS and exenatide Ended

2024-519014-31-00 Cardiovascular and metabolic diseases 2025-02-26
Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Ended

2024-514045-11-00 Partial Onset Seizures 2025-02-26
Characterization of Immune Response in Participants from a Posdinemab Study Ended

2024-514634-20-00 Early Alzheimer's disease 2025-02-25
A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting con… Ended

2024-518764-13-00 distal renal tubular acidosis (dRTA) 2025-02-25